1. Report Introduction

2. JAKAFI Overview in Polycythemia Vera
2.1. Product Detail
2.2. Clinical Development
2.2.1. Clinical Studies
2.2.2. Clinical Trials Information
2.2.3. Safety and Efficacy
2.3. Other Development Activities
2.4. Product Profile

3. Competitive Landscape (Marketed Therapies)

4. Competitive Landscape (Late-stage Emerging Therapies)*

5. JAKAFI Market Assessment
5.1. Market Outlook of JAKAFI in Polycythemia Vera
5.2. 7MM Market Analysis
5.2.1. Market Size of JAKAFI in the 7MM for Polycythemia Vera
5.3. Country-wise Market Analysis
5.3.1. Market Size of JAKAFI in the United States for Polycythemia Vera
5.3.2. Market Size of JAKAFI in Germany for Polycythemia Vera
5.3.3. Market Size of JAKAFI in France for Polycythemia Vera
5.3.4. Market Size of JAKAFI in Italy for Polycythemia Vera
5.3.5. Market Size of JAKAFI in Spain for Polycythemia Vera
5.3.6. Market Size of JAKAFI in the United Kingdo1m for Polycythemia Vera
5.3.7. Market Size of JAKAFI in Japan for Polycythemia Vera

6. SWOT Analysis

7. Analysts' Views

8. Appendix
8.1. Bibliography
8.2. Report Methodology

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

12. Report Purchase Option

List of Tables
Table 1: JAKAFI Clinical Trial Description, 2022
Table 2: JAKAFI (Ruxolitinib): General Description
Table 3: Competitive Landscape (Marketed Therapies)
Table 4: Competitive Landscape (Emerging Therapies)
Table 5: JAKAFI (Ruxolitinib) Market Size in the 7MM, in USD million (2019-2032)
Table 6: JAKAFI (Ruxolitinib) Market Size in the United States, in USD million (2019-2032)
Table 7: JAKAFI (Ruxolitinib) Market Size in Germany, in USD million (2019-2032)
Table 8: JAKAFI (Ruxolitinib) Market Size in France, in USD million (2019-2032)
Table 9: JAKAFI (Ruxolitinib) Market Size in Italy, in USD million (2019-2032)
Table 10: JAKAFI (Ruxolitinib) Market Size in Spain, in USD million (2019-2032)
Table 11: JAKAFI (Ruxolitinib) Market Size in the United Kingdom, in USD million (2019-2032)
Table 12: JAKAFI (Ruxolitinib) Market Size in Japan, in USD million (2019-2032)

List of Figures
Figure 1: Market Size of JAKAFI (Ruxolitinib) in the 7MM, in USD million (2019-2032)
Figure 2: Market Size of JAKAFI (Ruxolitinib) in the United States, in USD million (2019-2032)
Figure 3: Market Size of JAKAFI (Ruxolitinib) in Germany, in USD million (2019-2032)
Figure 4: Market Size of JAKAFI (Ruxolitinib) in France, in USD million (2019-2032)
Figure 5: Market Size of JAKAFI (Ruxolitinib) in Italy, in USD million (2019-2032)
Figure 6: Market Size of JAKAFI (Ruxolitinib) in Spain, in USD million (2019-2032)
Figure 7: Market Size of JAKAFI (Ruxolitinib) in United Kingdom, in USD million (2019-2032)
Figure 8: Market Size of JAKAFI (Ruxolitinib) in Japan, in USD million (2019-2032)